Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Detection of Antimicrobial Resistance-Related Changes in Biochemical Composition of Staphylococcus aureus by Means of Atomic Force Microscopy-Infrared Spectroscopy.

Kochan K, Nethercott C, Perez Guaita D, Jiang JH, Peleg AY, Wood BR, Heraud P.

Anal Chem. 2019 Dec 6. doi: 10.1021/acs.analchem.9b01671. [Epub ahead of print]

PMID:
31755705
2.

The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients.

Gardiner BJ, Chow JK, Brilleman SL, Peleg AY, Snydman DR.

Transpl Infect Dis. 2019 Oct 3:e13189. doi: 10.1111/tid.13189. [Epub ahead of print]

PMID:
31581352
3.

Daptomycin-resistant Staphylococcus aureus clinical isolates are poorly sensed by dendritic cells.

Patton T, Jiang JH, Lundie RJ, Bafit M, Gao W, Peleg AY, O'Keeffe M.

Immunol Cell Biol. 2019 Sep 26. doi: 10.1111/imcb.12295. [Epub ahead of print]

PMID:
31559654
4.

Unstable chromosome rearrangements in Staphylococcus aureus cause phenotype switching associated with persistent infections.

Guérillot R, Kostoulias X, Donovan L, Li L, Carter GP, Hachani A, Vandelannoote K, Giulieri S, Monk IR, Kunimoto M, Starrs L, Burgio G, Seemann T, Peleg AY, Stinear TP, Howden BP.

Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20135-20140. doi: 10.1073/pnas.1904861116. Epub 2019 Sep 16.

5.

Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning.

Baggio D, Peel T, Peleg AY, Avery S, Prayaga M, Foo M, Haffari G, Liu M, Bergmeir C, Ananda-Rajah M.

J Clin Med. 2019 Sep 5;8(9). pii: E1390. doi: 10.3390/jcm8091390.

6.

Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.

Bilal H, Bergen PJ, Kim TH, Chung SE, Peleg AY, Oliver A, Nation RL, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01293-19. doi: 10.1128/AAC.01293-19. Print 2019 Nov.

PMID:
31427301
7.

The Mechanisms of Disease Caused by Acinetobacter baumannii.

Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY.

Front Microbiol. 2019 Jul 17;10:1601. doi: 10.3389/fmicb.2019.01601. eCollection 2019. Review.

8.

A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Ooi JD, Jiang JH, Eggenhuizen PJ, Chua LL, van Timmeren M, Loh KL, O'Sullivan KM, Gan PY, Zhong Y, Tsyganov K, Shochet LR, Ryan J, Stegeman CA, Fugger L, Reid HH, Rossjohn J, Heeringa P, Holdsworth SR, Peleg AY, Kitching AR.

Nat Commun. 2019 Jul 29;10(1):3392. doi: 10.1038/s41467-019-11255-0.

9.

Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Smibert O, Satlin MJ, Nellore A, Peleg AY.

Curr Infect Dis Rep. 2019 Jun 10;21(7):26. doi: 10.1007/s11908-019-0679-4. Review.

PMID:
31183574
10.

Biofilm formation and migration on ventricular assist device drivelines.

Qu Y, McGiffin D, Kure C, Ozcelik B, Fraser J, Thissen H, Peleg AY.

J Thorac Cardiovasc Surg. 2019 Mar 6. pii: S0022-5223(19)30556-2. doi: 10.1016/j.jtcvs.2019.02.088. [Epub ahead of print]

PMID:
30955967
11.

A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016.

Valentine JC, Morrissey CO, Tacey MA, Liew D, Patil S, Peleg AY, Ananda-Rajah MR.

BMC Infect Dis. 2019 Mar 21;19(1):274. doi: 10.1186/s12879-019-3901-y.

12.

Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation.

Jiang JH, Bhuiyan MS, Shen HH, Cameron DR, Rupasinghe TWT, Wu CM, Le Brun AP, Kostoulias X, Domene C, Fulcher AJ, McConville MJ, Howden BP, Lieschke GJ, Peleg AY.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3722-3727. doi: 10.1073/pnas.1812066116. Epub 2019 Feb 11.

13.

Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Gardiner BJ, Stewardson AJ, Abbott IJ, Peleg AY.

Aust Prescr. 2019 Feb;42(1):14-19. doi: 10.18773/austprescr.2019.002. Epub 2019 Feb 1. Review. No abstract available.

14.

Fatal disseminated visceral varicella zoster virus infection in a renal transplant recipient.

Loftus MJ, Yong MK, Wilson S, Peleg AY.

Transpl Infect Dis. 2019 Jun;21(3):e13062. doi: 10.1111/tid.13062. Epub 2019 Mar 7.

PMID:
30756453
15.

Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.

Rees VE, Deveson Lucas DS, López-Causapé C, Huang Y, Kotsimbos T, Bulitta JB, Rees MC, Barugahare A, Peleg AY, Nation RL, Oliver A, Boyce JD, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02538-18. doi: 10.1128/AAC.02538-18. Print 2019 Apr.

16.

Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies.

Jiang JH, Hassan KA, Begg SL, Rupasinghe TWT, Naidu V, Pederick VG, Khorvash M, Whittall JJ, Paton JC, Paulsen IT, McDevitt CA, Peleg AY, Eijkelkamp BA.

MBio. 2019 Feb 5;10(1). pii: e02056-18. doi: 10.1128/mBio.02056-18.

17.

Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.

Jiang JH, Dexter C, Cameron DR, Monk IR, Baines SL, Abbott IJ, Spelman DW, Kostoulias X, Nethercott C, Howden BP, Peleg AY.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01926-18. doi: 10.1128/AAC.01926-18. Print 2019 Mar.

18.

OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.

Yang Y, Xu Q, Li T, Fu Y, Shi Y, Lan P, Zhao D, Chen Q, Zhou Z, Jiang Y, Peleg AY, Yu Y.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01676-18. doi: 10.1128/AAC.01676-18. Print 2019 Jan. No abstract available.

19.

A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation.

Westall GP, Cristiano Y, Levvey BJ, Whitford H, Paraskeva MA, Paul E, Peleg AY, Snell GI.

Transplantation. 2019 May;103(5):1005-1013. doi: 10.1097/TP.0000000000002454.

PMID:
30247316
20.

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.

Supplemental Content

Loading ...
Support Center